142 related articles for article (PubMed ID: 10844116)
1. 1,5-Anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice.
Ahrén B; Holst JJ; Yu S
Eur J Pharmacol; 2000 May; 397(1):219-25. PubMed ID: 10844116
[TBL] [Abstract][Full Text] [Related]
2. Effects of GLP-1 and 2,5-anhydro-D-mannitol on insulin secretion and plasma glucose in mice.
Ahrén B; Lindskog S; van Dijk G; Scheurink AJ; Steffens AB
Endocr Res; 1995 Aug; 21(3):583-94. PubMed ID: 7588428
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion.
Pørksen N; Grøfte B; Nyholm B; Holst JJ; Pincus SM; Veldhuis JD; Schmitz O; Butler PC
Diabetes; 1998 Jan; 47(1):45-9. PubMed ID: 9421373
[TBL] [Abstract][Full Text] [Related]
4. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.
Reimer MK; Holst JJ; Ahrén B
Eur J Endocrinol; 2002 May; 146(5):717-27. PubMed ID: 11980629
[TBL] [Abstract][Full Text] [Related]
5. Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.
Ahrén B; Pacini G
Am J Physiol; 1999 Dec; 277(6):E996-E1004. PubMed ID: 10600787
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
8. Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.
Ahrén B; Holst JJ; Mårtensson H; Balkan B
Eur J Pharmacol; 2000 Sep; 404(1-2):239-45. PubMed ID: 10980284
[TBL] [Abstract][Full Text] [Related]
9. Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice.
Ahrén B
Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R269-72. PubMed ID: 14707011
[TBL] [Abstract][Full Text] [Related]
10. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.
Liu L; Wang F; Lu H; Ren X; Zou J
Islets; 2014; 6(4):e962386. PubMed ID: 25437377
[TBL] [Abstract][Full Text] [Related]
11. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
12. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
Quddusi S; Vahl TP; Hanson K; Prigeon RL; D'Alessio DA
Diabetes Care; 2003 Mar; 26(3):791-8. PubMed ID: 12610039
[TBL] [Abstract][Full Text] [Related]
14. PACAP contributes to insulin secretion after gastric glucose gavage in mice.
Filipsson K; Holst JJ; Ahrén B
Am J Physiol Regul Integr Comp Physiol; 2000 Aug; 279(2):R424-32. PubMed ID: 10938228
[TBL] [Abstract][Full Text] [Related]
15. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line.
Gribble FM; Williams L; Simpson AK; Reimann F
Diabetes; 2003 May; 52(5):1147-54. PubMed ID: 12716745
[TBL] [Abstract][Full Text] [Related]
16. Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans.
Ahrén B; Holst JJ; Mari A
Diabetes Care; 2003 Oct; 26(10):2860-4. PubMed ID: 14514592
[TBL] [Abstract][Full Text] [Related]
17. Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas.
Jia X; Elliott R; Kwok YN; Pederson RA; McIntosh CH
Diabetes; 1995 May; 44(5):495-500. PubMed ID: 7729605
[TBL] [Abstract][Full Text] [Related]
18. Insulin secretion defects in liver cirrhosis can be reversed by glucagon-like peptide-1.
Siegel EG; Seidenstücker A; Gallwitz B; Schmitz F; Reinecke-Lüthge A; Klöppel G; Fölsch UR; Schmidt WE
J Endocrinol; 2000 Jan; 164(1):13-9. PubMed ID: 10607933
[TBL] [Abstract][Full Text] [Related]
19. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice.
Salehi A; Dornonville de la Cour C; Håkanson R; Lundquist I
Regul Pept; 2004 May; 118(3):143-50. PubMed ID: 15003830
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects.
Kong MF; Chapman I; Goble E; Wishart J; Wittert G; Morris H; Horowitz M
Peptides; 1999; 20(5):545-51. PubMed ID: 10465505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
